Beam Therapeutics Inc. (BEAM)
BMV
Real-time Data
02:30 PM
Day's Range
439.0052 wk Range
398.00Profile - BEAM - Beam Therapeutics Inc.
Profile
Mic Code
XMEX
Sector
Healthcare
Industry
Biotechnology
Employees
540
Beam Therapeutics Inc. is a biotechnology company focused on developing precision genetic medicines using its proprietary base editing platform. The company works on therapies designed to make targeted, single-letter changes in DNA without creating double-strand breaks, supporting programs aimed at serious genetic and hematologic diseases. Its current pipeline includes research and clinical candidates across areas such as blood disorders, liver diseases, and other rare conditions. Beam Therapeutics also maintains integrated capabilities in gene editing, delivery, and internal manufacturing to support the development of its therapeutic candidates. Based in Cambridge, Massachusetts, Beam Therapeutics plays a role in the advanced genomics and gene-editing market, where precision medicine approaches are being applied to address diseases with limited treatment options.
Profile Details
Type
Common Stock
Address
238 Main Street
City
Cambridge
State
MA
Zip
02142
Country
United States
Phone
857 327 8775
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
